Cargando…

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents

Nucleosomes positioned on the HIV-1 5′ long terminal repeat (LTR) regulate sense transcription as well as the establishment and maintenance of latency. A negative-sense promoter (NSP) in the 3′ LTR expresses antisense transcripts with coding and non-coding activities. Previous studies identified cis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rui, Caico, Isabella, Xu, Ziyan, Iqbal, Mohammad Shameel, Romerio, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844351/ https://www.ncbi.nlm.nih.gov/pubmed/36649034 http://dx.doi.org/10.3390/ncrna9010005

Ejemplares similares

The HIV-1 Antisense Gene ASP: The New Kid on the Block
por: Gholizadeh, Zahra, et al.
Publicado: (2021)

HIV-1 Natural Antisense Transcription and Its Role in Viral Persistence
por: Li, Rui, et al.
Publicado: (2021)

Origin and functional role of antisense transcription in endogenous and exogenous retroviruses
por: Romerio, Fabio
Publicado: (2023)

Identification and mapping of post-transcriptional modifications on the HIV-1 antisense transcript Ast in human cells
por: Estevez, Mariana, et al.
Publicado: (2022)

Extending the Coding Potential of Viral Genomes with Overlapping Antisense ORFs: A Case for the De Novo Creation of the Gene Encoding the Antisense Protein ASP of HIV-1
por: Pavesi, Angelo, et al.
Publicado: (2022)

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
por: Denton, Paul W.
Publicado: (2022)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

NSC95397 is a Novel HIV Latency Reversing Agent
por: Nichols Doyle, Randilea, et al.
Publicado: (2023)

Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch
por: Venkatachari, Narasimhan J., et al.
Publicado: (2015)

Sensing of HIV-1 by TLR8 activates human T cells and reverses latency
por: Meås, Hany Zekaria, et al.
Publicado: (2020)

Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
por: Mbonye, Uri, et al.
Publicado: (2011)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen
por: Liu, Hongbing, et al.
Publicado: (2021)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Epigenetic Heterogeneity in HIV-1 Latency Establishment
por: Matsuda, Yuka, et al.
Publicado: (2015)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
por: Gupta, Vipul, et al.
Publicado: (2018)

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells
por: Boucau, Julie, et al.
Publicado: (2020)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
por: Taylor, Jared P., et al.
Publicado: (2020)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
por: Li, Shifei, et al.
Publicado: (2023)

Latency Reversing Agents: Kick and Kill of HTLV-1?
por: Schnell, Annika P., et al.
Publicado: (2021)

Impact of latency‐reversing agents on human macrophage physiology
por: Hany, Laurent, et al.
Publicado: (2022)

Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR
por: Haddad, Fadia, et al.
Publicado: (2007)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

An effort to make sense of antisense transcription in bacteria
por: Lasa, Iñigo, et al.
Publicado: (2012)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Epigenetic regulation of human cis-natural antisense transcripts
por: Conley, Andrew B., et al.
Publicado: (2012)

Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
por: Kauder, Steven E., et al.
Publicado: (2009)

A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61
por: Depledge, Daniel P., et al.
Publicado: (2018)

Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
por: Khan, Sheraz, et al.
Publicado: (2018)

The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016)

Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?
por: Vignesh, Ramachandran, et al.
Publicado: (2017)

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2019)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
por: Ait-Ammar, Amina, et al.
Publicado: (2020)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
por: Salahong, Thanarat, et al.
Publicado: (2021)

HIV-1 transcription and latency: an update
por: Van Lint, Carine, et al.
Publicado: (2013)

Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents
por: Vollbrecht, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tshofh5q6mb52nhls5krln63gq